Goldman Sachs Group »

Cogent Biosciences shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 447k 5.88
2023-09-30 $3.9M 400k 9.75
2023-06-30 $4.3M 365k 11.84
2023-03-31 $6.0M 554k 10.79
2022-12-31 $7.5M 646k 11.56
2022-06-30 $3.3M 370k 9.02
2022-03-31 $1.3M 179k 7.49
2021-12-31 $679k 79k 8.58
2021-09-30 $1.3M 150k 8.41
2021-03-31 $341k 39k 8.77
2020-12-31 $116k 10k 11.25